Oct 21, 2021

Featuring perspectives from Drs Muhamed Baljevic, Joseph Mikhael and Nina Shah, moderated by Dr Robert Orlowski:

• Introduction (0:00)
• Up-Front Management of Newly Diagnosed Multiple Myeloma — Robert Z Orlowski, MD, PhD
• Selection and Sequencing of Therapies for Patients with Relapsed/Refractory Multiple Myeloma — Joseph Mikhael, MD (32:36)
• CAR (Chimeric Antigen Receptor) T-Cell Therapy for Relapsed/Refractory Multiple Myeloma — Nina Shah, MD (50:28)
• Novel Agents and Strategies Under Investigation in Multiple Myeloma — Muhamed Baljevic, MD (1:10:11)

CME information and select publications